HHS Nominee Price's Stock Picks To Surface At Confirmation Hearings

17 Jan 2017

• By Sue Darcey

Questions about US Health and Human Services Secretary nominee Tom Price's investments over the last year – including in Zimmer Biomet – and overlapping legislation he has introduced are likely to be raised at confirmation hearing before the Senate HELP Committee this week. However, Zimmer Biomet and other device firms have been trying to profit from the business models that Price opposes.

Leaders of a key US Senate health committee are expected to grill incoming President Donald Trump's pick for Health and Human Services Secretary, Rep. Tom Price, R-Ga., this week about his investments in health-care firms over the past year, including in the orthopedic device firm Zimmer Biomet Holdings Inc.

Among the issues that have been raised is that the HHS Secretary-nominee purchased between $1,001 to $15,000 worth of Zimmer Biomet shares in March 2016, according to congressional records, about...

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

20 May 2025

• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

20 May 2025

• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.